Search Results - "Gunby, Rosalind H."
-
1
-
2
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
Published in The lancet oncology (01-02-2003)“…Imatinib (STI571 or CGP57148B) is an innovative treatment for tumours with a constitutively activated form of c-ABL, c-KIT, or PDGFR. Such tumours include…”
Get more information
Journal Article -
3
Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase
Published in The Journal of biological chemistry (15-02-2008)“…NPM/ALK is an oncogenic fusion protein expressed in ∼50% of anaplastic large cell lymphoma cases. It derives from the t(2;5)(p23;q35) chromosomal translocation…”
Get full text
Journal Article -
4
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma
Published in Blood (01-10-2007)“…The oncogenic fusion tyrosine kinase nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) induces cellular transformation in anaplastic large-cell lymphomas…”
Get full text
Journal Article -
5
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State
Published in Small (Weinheim an der Bergstrasse, Germany) (01-04-2022)“…Circulating tumor cell (CTC) clusters are associated with increased metastatic potential and worse patient prognosis, but are rare, difficult to count, and…”
Get full text
Journal Article -
6
Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity
Published in Biochemistry (Easton) (14-06-2005)“…The anaplastic lymphoma kinase (ALK), whose constitutively active fusion proteins are responsible for 5−10% of non-Hodgkin's lymphomas, shares with the other…”
Get full text
Journal Article -
7
A Mechanistic Design Principle for Protein Tyrosine Kinase Sensors: Application to a Validated Cancer Target
Published in Organic letters (17-01-2008)“…A new mechanistic principle for reporting the phosphorylation of tyrosine is described, which should prove applicable to even the most fastidious of protein…”
Get full text
Journal Article -
8
Characterization of compound 584, an Abl kinase inhibitor with lasting effects
Published in Haematologica (Roma) (01-05-2008)“…1 Department of Clinical Medicine, University of Milano-Bicocca, S. Gerardo Hospital, Monza, Italy 2 Pharmaceutical Biochemistry Group, School of…”
Get full text
Journal Article -
9
Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
Published in Cell death and differentiation (01-01-1998)“…Kinetic analysis of dexamethasone-induced apoptosis in the human lymphoblastoid cell line CCRF CEM C7A has revealed a point when cells, morphologically…”
Get full text
Journal Article -
10
Structural Insights into the ATP Binding Pocket of the Anaplastic Lymphoma Kinase by Site-Directed Mutagenesis, Inhibitor Binding Analysis, and Homology Modeling
Published in Journal of medicinal chemistry (21-09-2006)“…Anaplastic lymphoma kinase (ALK) is a valid target for anticancer therapy; however, potent ALK inhibitors suitable for clinical use are lacking. Because the…”
Get full text
Journal Article -
11
Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy
Published in Anti-cancer agents in medicinal chemistry (01-11-2007)“…Deregulated activation of protein tyrosine kinases (PTKs) is a frequent event underlying malignant transformation in many types of cancer. The formation of…”
Get more information
Journal Article -
12
Generation and Verification of a Three-Dimensional Model of the ALK Kinase Domain: ALK - a “Supermutant” of Abl
Published in Blood (16-11-2004)“…Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase that plays a key role in oncogenesis in a subset of non-Hodgkin's lymphomas, through the…”
Get full text
Journal Article -
13
CD40-Triggered Protein Tyrosine Phosphorylation on Vav and on Phosphatidylinositol 3-Kinase Correlates with Survival of the Ramos–Burkitt Lymphoma B Cell Line
Published in Cellular immunology (01-05-1997)“…Signals transduced through CD40 rescue cells of the Ramos–Burkitt lymphoma (Ramos-BL) B cell line from surface immunoglobulin M (sIgM)-triggered growth arrest…”
Get full text
Journal Article